Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of GnRH Antagonist (Cetrotide) Protocol, Instead of Agonist, to Prepare Recipients for Embryo Transfer

NCT00460642 is registered in ClinicalTrials.gov with Institute for Human Reproduction (IHR) as lead sponsor.

NCT NCT00460642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of GnRH Antagonist (Cetrotide) Protocol, Instead of Agonist, to Prepare Recipients for Embryo Transfer
Lead sponsor
Institute for Human Reproduction (IHR)
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2009
Enrollment
130 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infertility